Farallon Capital Partners, L.P.

6 filings 3 distinct issuers Active 2023-04-27 → 2026-05-29

Track Record

Total filings

1 SCHEDULE 13G · 3 SCHEDULE · 2 SC

Distinct issuers

50% issuer diversity

Median stake

7.03%

19,261,500 avg shares

AI briefs cached

0/6

intent-classified filings

Backtested Performance · post-filing returns (split + dividend adjusted)

Median 30d

-8.0%

across 3 filings · win rate 0%

Median 60d

-3.0%

across 3 filings · win rate 33%

Median 90d

+1.1%

across 3 filings · win rate 67%

Median 1y

+16.3%

across 2 filings · win rate 100%

Anchor: closest trading day on/after filing's date_of_event. Source: Yahoo Finance daily adj_close. Past performance is not indicative of future results.

Filings · 6 total

Filed	Form	Issuer	Stake	Shares
2026-05-29	SCHEDULE 13G	BridgeBio Pharma, Inc.BBIO	—	—	view →
2026-01-05	SCHEDULE	EXELIXIS, INC.EXEL	5.90%	15,709,500	view →
2025-05-20	SCHEDULE	EXELIXIS, INC.EXEL	6.80%	18,635,500	view →
2025-03-05	SCHEDULE	EXELIXIS, INC.EXEL	8.40%	23,439,500	view →
2023-11-07	SC	Cazoo Group Ltd	—	—	view →
2023-04-27	SC	Cazoo Group Ltd	—	—	view →

Alert me when Farallon Capital Partners, L.P. files anything

Free. We email you when criteria match. One-click unsubscribe in every email.

Track this filer's every move in real time.

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →